Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6.
作者信息
Sun Yi, Sun Fengxiang, Wei Qiang, Huang Jin, Duan Ruiqi
机构信息
Department of Urology, West China Hospital, Sichuan University, Chengdu, China.
Medical Examination Center, The Second People's Hospital of Liaocheng, Liaocheng, China.
出版信息
Eur Urol. 2021 Jan;79(1):e14-e15. doi: 10.1016/j.eururo.2020.10.002. Epub 2020 Oct 26.
PMID:33121827
Abstract
摘要
相似文献
1
Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6.回复：安德鲁·维克斯、西格丽德·V·卡尔森、马修·库珀伯格。临床试验证据表明，常规使用磁共振成像早期检测前列腺癌并无依据。《欧洲泌尿外科杂志》2020年；78卷：304 - 306页。
Eur Urol. 2021 Jan;79(1):e14-e15. doi: 10.1016/j.eururo.2020.10.002. Epub 2020 Oct 26.
2
Re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6: Prebiopsy MRI: Through the Looking Glass.回复：安德鲁·维克斯、西格丽德·V·卡尔森、马修·库珀伯格。临床试验证据无法证明磁共振成像用于前列腺癌早期检测的常规应用是合理的。《欧洲泌尿外科杂志》2020年；78卷：304 - 6页：活检前磁共振成像：透过镜子。
Eur Urol. 2020 Sep;78(3):310-313. doi: 10.1016/j.eururo.2020.06.005. Epub 2020 Jul 11.
3
Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6.回复孙毅、孙凤翔、魏强、黄瑾和段瑞琦致编辑的信，信的内容涉及：安德鲁·维克斯、西格丽德·V·卡尔森、马修·库珀伯格。临床试验证据无法证明磁共振成像用于前列腺癌早期检测的常规使用是合理的。《欧洲泌尿外科杂志》2020年；78卷：304 - 306页。
Eur Urol. 2021 Jan;79(1):e16. doi: 10.1016/j.eururo.2020.10.009. Epub 2020 Nov 3.
4
Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6. Prebiopsy MRI: Through the Looking Glass.对罗德里克·C·N·范登伯格、奥利维耶·鲁维耶尔和西奥多勒斯·范德·夸斯特致编辑的信的回复，信的主题为：安德鲁·维克斯、西格丽德·V·卡尔森、马修·库珀伯格。临床试验证据无法证明磁共振成像用于前列腺癌早期检测的常规使用是合理的。《欧洲泌尿外科杂志》2020年；78卷：304 - 306页。活检前磁共振成像：透过镜子。
Eur Urol. 2020 Sep;78(3):314-315. doi: 10.1016/j.eururo.2020.06.059. Epub 2020 Jul 4.
5
Re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72.
Eur Urol. 2021 Dec;80(6):e147-e148. doi: 10.1016/j.eururo.2021.09.021. Epub 2021 Sep 29.
6
Re: Sigrid V. Carlsson, Rebecka Arnsrud Godtman, Carl-Gustav Pihl, et al. Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial. Eur Urol. 2023;83:103-9.回复：西格丽德·V·卡尔松、丽贝卡·阿恩斯鲁德·戈特曼、卡尔 - 古斯塔夫·皮尔等。开始前列腺特异性抗原检测时年龄较轻与前列腺癌死亡率更大幅度降低相关：哥德堡基于人群的前列腺癌随机筛查试验的24年随访。《欧洲泌尿外科杂志》。2023年；83卷：103 - 109页。
Eur Urol. 2023 May;83(5):e137-e138. doi: 10.1016/j.eururo.2022.12.037. Epub 2023 Feb 9.
7
Re: Yaw A. Nyame, Matthew R. Cooperberg, Marcus G. Cumberbatch, et al. Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. Eur Urol 2022;82:341-51.
Eur Urol. 2023 Apr;83(4):e102. doi: 10.1016/j.eururo.2022.12.033. Epub 2023 Jan 18.
8
Reply to Francesco Montorsi, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72.回复弗朗切斯科·蒙托西、乔治·甘达利亚和阿尔贝托·布里甘蒂致编辑的信，主题为：安德鲁·J·维克斯。磁共振成像靶向对前列腺癌过度诊断和过度治疗的影响。《欧洲泌尿外科杂志》2021年；80:567 - 72。
Eur Urol. 2021 Dec;80(6):e149. doi: 10.1016/j.eururo.2021.09.020. Epub 2021 Sep 30.
9
Re: Giorgio Gandaglia, Freddie Bray, Matthew R. Cooperberg, et al. Prostate Cancer Registries: Current Status and Future Directions. Eur Urol 2015;68:e110.回复：乔治·甘达利亚、弗雷迪·布雷、马修·R·库珀伯格等人。前列腺癌登记处：现状与未来方向。《欧洲泌尿外科杂志》2015年；68卷：e110。
Eur Urol. 2015 Nov;68(5):e110. doi: 10.1016/j.eururo.2015.07.002. Epub 2015 Jul 13.
10
Re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur urol 2012;62:745-52.回复：弗里茨·H·施罗德、乔纳斯·胡戈松、西格丽德·卡尔松等。前列腺癌筛查可降低发生转移性疾病的风险：欧洲前列腺癌筛查随机研究（ERSPC）的结果。《欧洲泌尿外科杂志》2012年；62卷：745 - 52页。
Eur Urol. 2012 Nov;62(5):e89; author reply e90-1. doi: 10.1016/j.eururo.2012.07.031. Epub 2012 Jul 25.
Zotero 插件